BAYRY BAYER AG
- 7.603
- +0.003+0.03%
BAYER AG News
Regeneron Falls After Q1 Miss; Announces $3B Share Buybacks
Monsanto Will Consider Legal Options Regarding Application of Ruling to Other SVEC Verdicts
Monsanto Will Consider Legal Options Regarding Application of Ruling to Other SVEC Verdicts
Monsanto: SVEC Cases Represent Most of PCB-related Personal Injury Litigation Against Monsanto
Monsanto: SVEC Cases Represent Most of PCB-related Personal Injury Litigation Against Monsanto
Monsanto: Decision Reverses Initial Verdict of $185M, Remands Case Back to Trial Court for Further Proceedings
Monsanto: Decision Reverses Initial Verdict of $185M, Remands Case Back to Trial Court for Further Proceedings
Monsanto Wins Appeal Ruling in Erickson V. Monsanto
Monsanto Wins Appeal Ruling in Erickson V. Monsanto
Metagenomi, Moderna Terminate Gene Editing Collaboration
Bayer AG's Dividend Analysis
Bayer (BAYRY.US) gene therapy under development for congestive heart failure obtained US FDA fast track qualification
Recently, Bayer (BAYRY.US) and its wholly-owned independent operating subsidiary Asklepios BioPharmaceuticals (AskBio) announced that the US FDA has granted the AB-1002 project fast-track qualification.
Autoinjectors Market Size Is Set to Grow by USD 134.01 Billion From 2023-2027, AbbVie Inc., Amgen Inc. and Bayer AG, and More to Emerge as Some of the Key Vendors, Technavio
The global autoinjectors market size is estimated to grow by USD 134014.58 million from 2023 to 2027, according to Technavio. The market is estimated ...
Bayer's Investigational Gene Therapy for Heart Failure Gets US FDA Fast Track Designation
Bayer (BAYN.F) received the US Food and Drug Administration's fast track designation for AB-1002, its subsidiary's investigational gene therapy for congestive heart failure.
United States Pet Medication Market Insights Report 2024-2029 Featuring Prominent Vendors - Boehringer Ingelheim, Ceva, Elanco Animal Health, Merck, Zoetis, Bayer AG, and Novartis - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "U.S. Pet Medication Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering.The U.S. Pet Medication Market was valued at USD 13.21
Non-Hodgkin Lymphoma Therapeutics Market Size Is Set to Grow by USD 5.42 Billion From 2023-2027, AstraZeneca Plc, Baxter International Inc. and Bayer AG, and More to Emerge as Some of the Key Vendors, Technavio
The global non-hodgkin lymphoma therapeutics market size is estimated to grow by USD 5427.51 mn from 2023 to 2027, according to Technavio. The market ...
Bayer Dethroned as Germany's Top Drugmaker
Ginkgo Bioworks Acquires AgBiome's Platform Assets
Alphabet, Nasdaq, Spotify, Teck Resources And A Major Financial Stock On CNBC's 'Final Trades'
On CNBC's "Halftime Report Final Trades," Joshua Brown of Ritholtz Wealth Management said Nasdaq, Inc. (NASDAQ:NDAQ) is going higher. On April 9, Morgan Stanley analyst Michael Cyprys upgraded Nasdaq
Google, Bayer in Pact for AI-powered Radiology Tools
Bayer Wins Backing of Glass Lewis, ISS Despite Share Decline
Two shareholder proxy services recommended that investors vote in support of Bayer AG’s management and supervisory boards at this month’s annual shareholder meeting, even though the company’s shares recently fell to their lowest level since 2005.
Here's Why Bayer Aktiengesellschaft (BAYRY) Detracted in Q1
Phathom Pharma, Rhythm, Vaxcyte Most Likely Takeover Targets in Pharma - Analyst
Bayer Roundup Cancer Jury Award Cut by Nearly Two-thirds to $550M
Analysis
Price Target
No Data
